Network News

The German Ethics Council is an expert body that advises parliament and government on social and, above all, medical and bioethical issues. Eva Winkler, Heisenberg Professor for Translational Medical Ethics at the Heidelberg Faculty of Medicine of Heidelberg University, has now been appointed to the Council. As Managing Director at the National Centre for Tumour […]

NORTH CHICAGO, Ill., Oct. 17, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved VYALEV™ (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of motor fluctuations in adults with advanced Parkinson’s disease (PD). “For too long, the Parkinson’s community has had […]

IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of BOTOX® Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting the jaw and neck (platysma bands) in adults.1 BOTOX® Cosmetic is the first and only product with four aesthetic indication areas: forehead lines, frown lines, […]

Ruprecht Karls Prizes and Fritz Grunebaum Prize to be awarded on October 25 The Heidelberg University Foundation honors young academics with the Ruprecht Karls Prizes for their outstanding scientific publications. The awards go to five doctoral students from various disciplines. The Fritz Grunebaum Prize will also be awarded during the festive event in the auditorium […]

Every year, more than a million people die from tuberculosis. To date, there is no effective vaccination against the pathogen, and treatment is also lengthy and difficult due to increasing multiple resistances. As the bacterium Mycobacterium tuberculosis manages to defy both the immune system and antibiotic treatment, Dr. Vivek Thacker, group leader at the Medical Faculty Heidelberg […]

Dr. Tanja Eichkorn, a scientist at Heidelberg University and physician at the Department of Radiation Oncology and Radiotherapy at Heidelberg University Hospital, has been awarded the Anita and Friedrich Reutner Prize of the Heidelberg Medical Faculty for her research into tissue damage in the brain following high-precision radiation with protons. More Information in German below. […]

Further Information in German below. Promega entwickelt neues Enzym zur signifikanten Reduktion von Stutter-Artefakten in der forensischen DNA-Analyse Madison, WI USA. (30. September 2024)  Forschende der Promega Corporation haben ein neues Enzym entwickelt, das störende Stutter-Artefakte in der forensischen DNA-Analyse nahezu vollständig eliminiert. Dieses Enzym erleichtert erheblich die Dekonvolution von Mischspuren und ermöglicht Forensikerinnen und Forensikern, […]

Success for the NMI spin-off immuneAdvice: the startup took first place in the Young Scientists Pitch Competition at the bioRN Annual Conference on Wednesday, October 9, 2024. Dr. Björn Tränkle, one of the founders, presented the business idea. The vision of immuneAdvice is the early response monitoring and control of immunotherapies with the so-called ICE-T […]

YUMAB GmbH (“YUMAB”), a leading antibody discovery CRO headquartered in Braunschweig, Germany, and MOLCURE Inc. (“MOLCURE”), an AI-driven drug discovery company based in Kawasaki, Japan, announced their on-going collaboration now includes advancing the application of zero-shot AI technology for antibody discovery. The collaboration brings together complementary expertise and technologies. MOLCURE has a decade of experience […]